Haemonetics Corp (HAE)
85.43
+0.51
(+0.60%)
USD |
NYSE |
Nov 21, 16:00
85.46
+0.04
(+0.04%)
Pre-Market: 20:00
Haemonetics Total Liabilities (Quarterly): 1.646B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.646B |
| June 30, 2024 | 1.636B |
| March 31, 2024 | 1.236B |
| December 31, 2023 | 1.257B |
| September 30, 2023 | 1.118B |
| June 30, 2023 | 1.098B |
| March 31, 2023 | 1.117B |
| December 31, 2022 | 1.102B |
| September 30, 2022 | 1.136B |
| June 30, 2022 | 1.050B |
| March 31, 2022 | 1.110B |
| December 31, 2021 | 1.101B |
| September 30, 2021 | 1.103B |
| June 30, 2021 | 1.117B |
| March 31, 2021 | 1.088B |
| December 31, 2020 | 598.92M |
| September 30, 2020 | 750.25M |
| June 30, 2020 | 824.60M |
| March 31, 2020 | 680.00M |
| December 31, 2019 | 663.17M |
| September 30, 2019 | 606.79M |
| June 30, 2019 | 668.64M |
| March 31, 2019 | 606.90M |
| December 31, 2018 | 584.51M |
| September 30, 2018 | 564.37M |
| Date | Value |
|---|---|
| June 30, 2018 | 567.11M |
| March 31, 2018 | 484.91M |
| December 31, 2017 | 488.91M |
| September 30, 2017 | 469.91M |
| June 30, 2017 | 478.61M |
| March 31, 2017 | 499.10M |
| December 31, 2016 | 535.52M |
| September 30, 2016 | 585.71M |
| June 30, 2016 | 601.83M |
| March 31, 2016 | 597.56M |
| December 31, 2015 | 616.87M |
| September 30, 2015 | 642.06M |
| June 30, 2015 | 635.76M |
| March 31, 2015 | 659.30M |
| December 31, 2014 | 640.24M |
| September 30, 2014 | 653.83M |
| June 30, 2014 | 661.66M |
| March 31, 2014 | 676.29M |
| December 31, 2013 | 662.67M |
| September 30, 2013 | 687.77M |
| June 30, 2013 | 705.25M |
| March 31, 2013 | 692.74M |
| December 31, 2012 | 695.22M |
| September 30, 2012 | 682.59M |
| June 30, 2012 | 170.66M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
598.92M
Minimum
Dec 2020
1.646B
Maximum
Sep 2024
1.072B
Average
1.103B
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 17.12B |
| Baxter International Inc | 18.73B |
| Globus Medical Inc | 1.017B |
| ResMed Inc | 2.027B |
| Integra Lifesciences Holdings Corp | 2.544B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.525B |
| Shareholders Equity (Quarterly) | 878.85M |
| Debt to Equity Ratio | 1.394 |
| Current Ratio | 3.489 |
| Net Debt Paydown Yield | -2.27% |